![]() However, he admits to being ‘surprised’ by the news of its acquisition. He tells Chemistry World, through a representative, that he is ‘very proud’ of the progress that the company has made throughout the years, and hopes that the sale works out to everyone’s benefit. ‘We will commit the necessary resources to develop our pharma pipeline products further,’ Kley stated.Īlfred Bader, founder of the Aldrich Chemical Company, which merged with the Sigma Chemical Company in 1975 to become Sigma–Aldrich, is now 90 years old and has had several strokes in recent years. He emphasised that Merck is delivering ‘very stable sales’ on its existing pharma portfolio. In an online interview, Kley said Merck’s pharma business will continue to remain ‘an integral part’ of the company. ![]() ‘We want to take our life sciences business to the next level.’ ‘This is not an attempt to move away from pharma,’ Merck spokesman Markus Talanow tells Chemistry World. While fellow German conglomerate Bayer is separating its life science and materials segments, Merck is sticking to its integrated model. Merck insists that the purchase does not indicate that it is stepping back from drug development and research. For example, Merck itself bought US-based life sciences company Millipore for $7.2 billion (£4.8 billion at) in 2010 and last year, Thermo Fisher Scientific made a move into the growing next-generation sequencing market by acquiring Life Technologies – principally for its Ion Torrent sequencing subsidiary. The lab supplies area has seen significant consolidation in recent years. The deal will also add exposure to fast-growing Asian markets, the company suggests. Indeed, Merck believes that it is currently underrepresented in America, and says Sigma-Aldrich’s strong US presence will be an asset. The two companies have complementary product ranges and geographical reach. In a statement, Merck’s chairman, Karl-Ludwig Kley, called the acquisition a ‘quantum leap’ for the company’s life science business. Merck expects the merger to release approximately €260 million (£203 million) per year in cost savings and sales increases within three years of closing the deal. Merck is hoping its union with Sigma-Aldrich will bring prosperity and expand its presence in the US World History Archive / Alamy ( Portrait of a Couple by Frans Hals)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |